The Q3 earnings report for HealthEquity HQY was launched on Monday, December 9, 2024 at 04:01 PM.
Here is what buyers must know concerning the newest announcement.
Earnings
HealthEquity beat estimated earnings by 8.0%, reporting an EPS of $0.78 versus an estimate of $0.72.
Income was up $51.21 million from the identical interval final yr.
Earnings Historical past Overview
The corporate beat on EPS by $0.16 within the final quarter, leading to a 5.0% improve share worth change the next day.
Here is a have a look at HealthEquity’s previous efficiency:
| Quarter | Q2 2025 | Q1 2025 | This fall 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.70 | 0.66 | 0.56 | 0.5 |
| EPS Precise | 0.86 | 0.80 | 0.63 | 0.6 |
| Income Estimate | 284.87M | 278.11M | 258.55M | 243.61M |
| Income Precise | 299.93M | 287.60M | 262.39M | 249.22M |
New buyers ought to observe that it’s generally not an earnings beat or miss that the majority impacts the value of a inventory, however the steerage (or forecast).
Steerage
HealthEquity administration supplied steerage for FY 2025, anticipating earnings between $3.08 and $3.16 per share.
To trace all earnings releases for HealthEquity go to their earnings calendar right here.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Market Information and Knowledge delivered to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
